Sarah Cannon Research Institute
Tabitha Artz has extensive experience in clinical affairs and regulatory affairs, primarily at the Sarah Cannon Research Institute since September 2010. As Manager of Clinical Affairs, Tabitha leads a team, manages regulatory documentation, and oversees compliance with FDA and GCP standards. Tabitha's career progression at Sarah Cannon includes roles as Senior Clinical Research Associate and Lead Regulatory Affairs Specialist, where responsibilities included training staff, managing IRB submissions, and ensuring adherence to SOPs. Prior to this, Tabitha worked as Administrative Manager and Senior Project Manager at Seaboard Health Care Search, where expertise in physician placement was developed. Tabitha's educational background includes a Bachelor's degree in Journalism from Middle Tennessee State University and legal studies at The University of Memphis—Cecil C. Humphreys School of Law.
This person is not in any teams
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. In 2022, SCRI formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted nearly 700 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The combined research network brings together physicians who are actively accruing patients to clinical trials at more than 250 locations in 26 states across the US.